153209-97-3Relevant articles and documents
ORGANIC COMPOUNDS
-
Page/Page column 19, (2009/04/24)
Disclosed are δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amide compounds of formula (I)and the salts thereof, having renin-inhibiting properties. Also disclosed are pharmaceutical compositions comprising these compounds and methods of administering them for the treatment of hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, unstable coronary syndrome, diastolic dysfunction, chronic kidney disease, hepatic fibrosis, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty, raised intra-ocular pressure, glaucoma, abnormal vascular growth, hyperaldosteronism, cognitive impairment, alzheimers, dementia, anxiety states and cognitive disorders.
Double Isomerization of Oxetane Amides to Azetidine Esters with Ring Expansion and Contraction
Kanoh, Shigeyoshi,Nishimura, Tomonari,Kita, Yukiko,Ogawa, Hiroshi,Motoi, Masatoshi,Takani, Masako,Tanaka, Toshiyuki
, p. 2253 - 2256 (2007/10/05)
-
Chemoselective isomerization of amide-substituted oxetanes with Lewis acid to give oxazine derivatives or bicyclic amide acetals
Nishimura, Tomonari,Kanoh, Shigeyoshi,Senda, Hitoshi,Tanaka, Toshiyuki,Ando, Kohji,Ogawa, Hiroshi,Motoi, Masatoshi
, p. 43 - 44 (2007/10/03)
The Lewis-acid catalyzed isomerization of secondary and tertiary amide-substituted oxetanes takes place chemoselectively, giving 5-hydroxymethyl-5,6-dihydro-4H-1,3-oxazines and reactive amide acetals consisting of a bicyclo[2.2.2]octane skeleton, respectively.